US Stock MarketDetailed Quotes

TARO Taro Pharmaceutical Industries

Watchlist
  • 42.970
  • 0.0000.00%
Close Jun 25 09:30 ET
1.27BMarket Cap30.05P/E (TTM)

Taro Pharmaceutical Industries Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Taro Pharmaceutical Industries Earnings Date

Currency: USD

Period

Q4 FY2024 Earnings

May 20, 2024

Revenue(YoY)

164.94M

+12.52%
EPS(YoY)

0.40

+122.22%
Analyst Rating

No Data

Taro Pharmaceutical Industries Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
May 20, 20242024/Q4164.941M / 156.062M--
Jan 25, 20242024/Q3157.145M / 154.907M--
Oct 26, 20232024/Q2148.202M / 161.141M--
Jul 26, 20232024/Q1158.894M / 149.027M--
May 23, 20232023/Q4146.587M / 150.693M--
DatePeriodRevenue/EstimateEarnings Call
May 20, 20242024/Q4164.941M / 156.062M--
Jan 25, 20242024/Q3157.145M / 154.907M--
Oct 26, 20232024/Q2148.202M / 161.141M--
Jul 26, 20232024/Q1158.894M / 149.027M--
May 23, 20232023/Q4146.587M / 150.693M--

Unlock Free Earnings Estimates

Taro Pharmaceutical Industries Earnings Reports

  • Taro Pharmaceutical Industries | 6-K: Report of foreign private issuer (related to financial reporting)

    May 21 09:04 ET

  • Taro Pharmaceutical Industries | 6-K: Report of foreign private issuer (related to financial reporting)

    Jan 26 09:04 ET

  • Taro Pharmaceutical Industries | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 17, 2023 16:30 ET

  • Taro Pharmaceutical Industries | 6-K: Report of foreign private issuer (related to financial reporting)

    Oct 27, 2023 09:00 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Cannabis
    Cannabis
    Intraday+0.67%